Remunity® Pump for Remodulin® (treprostinil; United Therapeutics and DEKA) is now available for patients with pulmonary arterial hypertension (PAH).
Remunity Pump is intended for continuous subcutaneous delivery of Remodulin, a prostacyclin vasodilator, in prefilled cassettes for the treatment of PAH in adults aged 22 years and older. Prefilled Remodulin cassettes are delivered to patients by a specialty pharmacy with each cassette containing up to 3 days (72 hours) of medication.
Remunity is small (2 inches in diameter, ¾ inch thick, and weighs 1.7 ounces), water resistant, and can be programmed wirelessly using a separate remote. The pump is for use only with FDA-cleared infusion sets: Medtronic Quick-set Infusion Set (MMT-392, MMT-393), Medtronic Silhouette Infusion Set (MMT-373), and Smiths Medical Cleo 90 Infusion Set (21-7230-24, 21-7220-24).
“We are excited to bring to market the first subcutaneous pump designed specifically for PAH patients,” said Beth Rhodes, Vice President, Global Supply Chain & Alliance Management at United Therapeutics. “Remunity is a small, discreet pump that delivers Remodulin in prefilled cassettes that are delivered directly to patients, offering significant improvements over current subcutaneous pumps.”
For more information visit remodulin.com.
United Therapeutics announces commercial launch of the Remunity® Pump for Remodulin®. [press release]. Silver Spring, MD and Research Triangle Park, NC: United Therapeutics Corporation; February 10, 2021.